Liminal BioSciences to Report First Quarter 2022 Financial Results on May 10, 2022
LAVAL, QC and CAMBRIDGE, ENGLAND, May 9, 2022 /PRNewswire/ - Liminal BioSciences Inc. (NASDAQ: LMNL) ("Liminal BioSciences" or the "Company"), today announced that it plans to report its first quarter 2022 financial results after market close on May 10, 2021. Liminal will host a...
Read more »